Lakeshore Biopharma Co Stock Market Outlook
| LSBCF Stock | 0.13 0.03 18.75% |
Roughly 61% of LakeShore Biopharma's investor base is looking to short. The analysis of the overall investor sentiment regarding LakeShore Biopharma Co suggests that many traders are alarmed. The current market sentiment, together with LakeShore Biopharma's historical and current headlines, can help investors time the market. In addition, many technical investors use LakeShore Biopharma stock news signals to limit their universe of possible portfolio assets.
Comfort Level 39
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use LakeShore Biopharma's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward LakeShore Biopharma Co.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Assuming the 90 days horizon and your complete indifference towards market risk, our recommendation regarding LakeShore Biopharma Co is 'Cautious Hold'. Macroaxis provides LakeShore Biopharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LSBCF positions.
LakeShore | Build AI portfolio with LakeShore Stock |
Execute LakeShore Biopharma Advice
The LakeShore recommendation should be used to complement the investment advice compiled from the current analysts' consensus on LakeShore Biopharma Co. Macroaxis does not own or have any residual interests in LakeShore Biopharma Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute LakeShore Biopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Weakest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Risky | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
For the selected time horizon LakeShore Biopharma Co has a Mean Deviation of 4.23, Standard Deviation of 9.31 and Variance of 86.62We provide investment recommendation to complement the last-minute expert consensus on LakeShore Biopharma Co. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. Please exercise LakeShore Biopharma number of employees and working capital to make buy, hold, or sell decision on LakeShore Biopharma Co. As LakeShore Biopharma appears to be a penny stock we also strongly suggest to check its number of employees numbers.
LakeShore Biopharma Trading Alerts and Improvement Suggestions
| LakeShore Biopharma generated a negative expected return over the last 90 days | |
| LakeShore Biopharma has high historical volatility and very poor performance | |
| LakeShore Biopharma has some characteristics of a very speculative penny stock | |
| LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 614.96 M. Net Loss for the year was (99.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LakeShore Biopharma generates negative cash flow from operations | |
| Latest headline from news.google.com: Buyer group questions LakeShore Biopharma take-private after RMB576.5m liability - stocktitan.net |
LakeShore Biopharma Returns Distribution Density
The distribution of LakeShore Biopharma's historical returns is an attempt to chart the uncertainty of LakeShore Biopharma's future price movements. The chart of the probability distribution of LakeShore Biopharma daily returns describes the distribution of returns around its average expected value. We use LakeShore Biopharma Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of LakeShore Biopharma returns is essential to provide solid investment analysis for LakeShore Biopharma.
| Mean Return | -2.16 | Value At Risk | -18.75 | Potential Upside | 2.41 | Standard Deviation | 9.31 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of LakeShore Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
LakeShore Biopharma Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change To Inventory | (89.5M) | (18.2M) | (86.3M) | (24.2M) | (27.8M) | (29.2M) | |
| Change In Cash | (119.4M) | 99.3M | (123.8M) | (139.1M) | (125.2M) | (118.9M) | |
| Free Cash Flow | (299.5M) | (239.5M) | (339.5M) | (138.8M) | (159.7M) | (167.6M) | |
| Depreciation | 31.2M | 36.7M | 42.2M | 36.7M | 42.1M | 38.4M | |
| Other Non Cash Items | 27.3M | 14.4M | 153.8M | 48.5M | 55.8M | 54.8M | |
| Capital Expenditures | 298.9M | 57.0M | 44.3M | 17.9M | 16.1M | 15.3M | |
| Net Income | (106.0M) | (145.5M) | (433.5M) | (100.0M) | (90.0M) | (94.5M) | |
| End Period Cash Flow | 885.2K | 370.4M | 246.6M | 107.5M | 96.7M | 178.5M |
LakeShore Biopharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to LakeShore Biopharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that LakeShore Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a LakeShore stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -2.02 | |
β | Beta against Dow Jones | -2.38 | |
σ | Overall volatility | 9.62 | |
Ir | Information ratio | -0.24 |
LakeShore Biopharma Volatility Alert
LakeShore Biopharma Co is displaying above-average volatility over the selected time horizon. LakeShore Biopharma Co is a potential penny stock. Although LakeShore Biopharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in LakeShore Biopharma Co. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on LakeShore instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.LakeShore Biopharma Fundamentals Vs Peers
Comparing LakeShore Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze LakeShore Biopharma's direct or indirect competition across all of the common fundamentals between LakeShore Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as LakeShore Biopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of LakeShore Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing LakeShore Biopharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare LakeShore Biopharma to competition |
| Fundamentals | LakeShore Biopharma | Peer Average |
| Revenue | 614.96 M | 9.43 B |
| EBITDA | (48.54 M) | 3.9 B |
| Net Income | (99.98 M) | 570.98 M |
| Total Debt | 414.4 M | 5.32 B |
| Cash Flow From Operations | (120.98 M) | 971.22 M |
| Number Of Employees | 758 | 18.84 K |
| Total Asset | 1.37 B | 29.47 B |
| Retained Earnings | (2.41 B) | 9.33 B |
| Working Capital | 17.47 M | 1.48 B |
| Net Asset | 1.37 B |
LakeShore Biopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as LakeShore . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 0.81 | |||
| Day Median Price | 0.13 | |||
| Day Typical Price | 0.13 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.03) |
About LakeShore Biopharma Buy or Sell Advice
When is the right time to buy or sell LakeShore Biopharma Co? Buying financial instruments such as LakeShore Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having LakeShore Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Growth Funds Thematic Idea Now
Small Growth Funds
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out LakeShore Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Can Biotechnology industry sustain growth momentum? Does LakeShore have expansion opportunities? Factors like these will boost the valuation of LakeShore Biopharma. Expected growth trajectory for LakeShore significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating LakeShore Biopharma demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding LakeShore Biopharma requires distinguishing between market price and book value, where the latter reflects LakeShore's accounting equity. The concept of intrinsic value - what LakeShore Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push LakeShore Biopharma's price substantially above or below its fundamental value.
Understanding that LakeShore Biopharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LakeShore Biopharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, LakeShore Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.